Abstract
Transforming growth factor alpha (TGF-a) and beta 2 (TGF-ß2) are present in human milk and are involved in growth differentiation and repair of neonatal intestinal epithelia. Heat treatment at 56°C has been shown effective for providing safe banked donor milk, with good retention of other biologically active factors. The purpose of our study was to determine the effect of heat sterilization on TGF-a and TGF-ß2 concentrations in human milk. Twenty milk samples were collected from 20 lactating mothers in polypropylene containers and frozen at -20°C for transport or storage. Before heat treatment by holder pasteurization, the frozen milk was thawed and divided into 1-mL aliquots. All samples were heated in an accurately regulated water bath until a holding temperature was achieved, then held for 30 minutes using constant agitation. Holding temperature ranged from 56.5°C to 56.9°C. The milk was then stored at 4°C overnight for analysis the following day. The concentration of TGF-a was measured by radioimmunoassay. Mean concentration ± SD of TGF-a in raw milk samples was 119 ± 50 pg/mL, range 57 to 234. The mean concentration ± SD of TGF-a in heat treated samples was 113 ± 50 pg/mL, range 51 to 227. TGF-a concentration was minimally affected by pasteurization, with an overall loss of 6.1%. Of 19 samples, 4 had increased and 15 had decreased concentrations after pasteurization (mean percent ± SEM: 94% ± 7% of raw milk, range 72%-107%). The concentration of acid-activated TGF- 32 was measured by enzyme-linked immunosorbent assay. Mean concentration ± SD of TGF- 32 in raw milk samples was 5624 ± 5038 pg/mL, range 195 to 15480. The mean concentration ± SD of TGF-ß2 in heat-treated samples was 5073 ± 4646pg/mL, range 181 to 15140. TGF-ß2 survived with relatively little loss (0.6%): of 18 samples, 11 had increased and 7 had decreased concentrations after pasteurization (mean percent ± SEM: 99.4 ± 6.7% of raw milk, range 79%-120%). In conclusion, both TGF-a and TGF-132 were well-preserved in whole milk after holder pasteurization at 56.5°C. The relative increase in growth factor concentration in some of the samples may be attributable to the release of that factor from the cellular and/or fat compartments into the aqueous fraction of human milk These findings have implications regarding use of donor milk as an alternate source of growth factors and cytokines for the newborn gut when mother’s milk is unavailable.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
[AAP] American Academy of Pediatrics. The promotion of breastfeeding: Policy statement based on task force report. Pediatrics 1982;69:654–661.
Adams DH, Hathaway M, Shaw J, Burnett D, Elias E, Strain AJ. Transforming growth factor beta induces human T lymphocyte migration in vitro. J Immunol 1991;147:609–612.
Arnold LDW, Tully MR. Guidelines for the Establishment and Operation of a Donor Human Milk Bank. West Hartford CT: Human Milk Banking Association of North America, Inc.; 1996. p. 1.
Asquith MT, Pedrotti PW, Stevenson DK, Sunshine P. Clinical uses, collection, and banking of human milk. Clin Perinatol 1987;14:173–185.
Balmer SE, Williams AF. Guidelines for the establishment and operation of human milk banks in the UK. Arch Dis Child 1995;73:481–482.
Barnard JA, Beauchamp RD, Coffey RJ, Moses HL. Regulation of intestinal epithelial cell growth by transforming growth factor type beta. Proc Natl Acad Sci USA 1989;86:1578–1582.
Bines JE, Walker WA. Growth factors and the development of neonatal host defense. Adv Exp Med Biol 1991;310:31–39.
Ciacci C, Lind SE, Podolsky DK. Transforming growth factor beta regulation of migration in wounded rat intestinal epithelial monolayers. Gastroenterology 1993;105:93–101.
Coffman RL, Lebman DA, Shrader B. Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J Exp Med 1989;170:1039–1044.
Derynck R. The physiology of transforming growth factor alpha. Adv Cancer Res 1992;58:27–51. Dignass AU, Podolsky DK. Cytokine modulation of intestinal epithelial cell restitution: Central role of transforming growth factor beta. Gastroenterology 1993;105:1323–1332.
Dignass AU, Stow JL, Babyatsky MW Acute epithelial injury in the rat small intestine in vivo is associated with expanded expression of transforming growth factor alpha and beta. Gut 1996;38:687–693.
Donnet-Hughes EJ, Schiffrin EJ, Huggett AC. Expression of MHC antigens by intestinal epithelial cells. Effect of transforming growth factor-beta 2 (TGF-132). Clin Exp Immunol 1995;99:240–244.
Ehrhardt RO, Strober W, Harriman GR. Effect of transforming growth factor (TGF)-beta 1 on IgA isotype expression. TGF-beta 1 induces a small increase in sIgA+B cells regardless of the method of B cell activation. J Immunol 1992;148:3830–3836.
Eitenmiller RR. An overview of human milk pasteurization. Presentation at the annual meeting of the Human Milk Banking Association of North America, Inc.; Lexington KY; March 1, 1996.
Evans TJ, Ryley HC, Neale LM, Dodge JA, Lewarne VM. Effect of storage and heat on antimicrobial proteins in human milk. Arch Dis Childhood 1978;53:239–241.
Galliaerde V, Desvignes C, Peyron E, Kaiserlian D. Oral tolerance to haptens: intestinal epithelial cells from 2,4-dinitrochlorobenzene-fed mice inhibit hapten-specific T cell activation in vitro. Eur J Immunol 1995;25:1385–1390.
Karnes WE. Epidermal growth factor and transforming growth factor alpha. In: Walsh JH, Dockray GJ, eds. Gut Peptides: Biochemistry and Physiology. New York: Raven Press; 1994. pp. 553–586.
Kehrl JH, Taylor AS, Delsing GA, Roberts, AB, Sporn MB, Fauci AS. Further studies of the role of transforming growth beta in human B cell function. J Immunol 1989;143:1868–1874.
Koldovsky O, Britton J, Grimes J, Schaudies P. Milk-borne epidermal growth factor (EGF) and its processing in developing gastrointestinal tract. Endocr Regul 1991;25:58–62.
Kudlow JE, Bjorge JD. TGF alpha in normal physiology. Semin Cancer Biol 1990;1:293–302.
Laiho M, Keski-Oja J. Transforming growth factor-beta as regulators of cellular growth and phenotype. Crit Rev Oncog 1992;3:1–26.
Laker MF, Bull HJ, Menzies IS. Evaluation of mannitol for use as a probe marker of gastrointestinal permeability in man. Eur J Clin Invest 1982;12:485–491.
Letterio JJ, Roberts AB. TGF-beta: a critical modulator of immune cell function. Clin Immunol Immunopathol 1997;84:244–250.
Letterio JJ, Geiser AG, Kulkarni AB, Roche NS, Sporn MB, Roberts AB. Maternal rescue of transfroming growth factor-beta 1 null mice. Science 1994;264:1936–1938.
Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet 1990;336:1519–1523.
Lucas A, Morley R, Cole TJ, Lister G, Leeson-Payne C. Breast milk and subsequent intelligence quotient in children born preterm. Lancet 1992;339:261–264.
Okada M, Ohmura E, Kamiya Y, Murakami H, Onoda N, Iwashita M, Wakai K, Tsushima T, Shizume K. Transforming growth factor (TGF)-alpha in human milk. Life Sci 1991;48:1151–1156.
Raptopoulou-Gigi M, Marwick K, McClelland DB. Antimicrobial proteins in sterilized human milk. BMJ 1977;1:12–14.
Rognum TO, Thrane S, Stoltenburg L, Vege A, Brandtzaeg P. Development of intestinal mucosal immunity in fetal life and the first postnatal months. Pediatr Res 1992;32:145–149.
Saito S, Yoshida M, Ichijo M, Ishizaka S, Tsujii T. Transforming growth factor-beta (TGF-13) in human milk. Clin Exp Immunol 1993;94:220–224.
Saunders DR, Wiggins HS. Conservation of mannitol, lactulose, and raffinose by the human colon. Am J Physiol 1981;241:G397–G402.
Schanler RJ. Human milk for the premature infant. ABM News and Views 1997;3:1–6.
Snapper CM, Waegell W, Beernink H, Dasch JR. Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro. J Immunol 1993; 151:4625–4636.
Srivastava MD, Srivastava A, Brouhard B, Saneto R, Groh-Wargo S, Kubit J. Cytokines in human milk. Res Commun Mol Pathol Pharmacol 1996;93:263–287.
Thornburg W, Matrisian L, Magun B, Koldovsky O. Gastrointestinal absorption of epidermal growth factor in suckling rats. Am J Physiol 1984;246:G80–G85.
Van Zoeren-Grobben D, Schrijver J, Van den Berg H, Berger HM. Human milk vitamin content after pasteurisation, storage, or tube feeding. Arch Dis Child 1987;62:161–165.
Wagner CL, Forsythe DM, Pittard WB III. Variation in the biochemical forms of transforming growth factor-alpha present in human milk and secreted by human milk macrophages. Biol Neonate 1995;68:325–333.
Wardell JM, Wright AJ, Bardsley WG, D’Souza SW. Bile salt-stimulated lipase and esterase activity in human milk after collection, storage, and heating: nutritional implications. Pediatr Res 1984; 18:382–386.
[WHO/UNICEF] World Health Organization/United Nations Children’s Fund Joint Statement. Meeting on Infant and Child Nutrition. J Nurse-Midwifery 1980;25:31–38.
Yasui W, Ji ZQ, Kuniyasu H, Ayhan A, Yokozaki H, Ito H, Tahara E. Expression of transforming growth factor alpha in human tissues: immunohistochemical study and northern blot analysis. Virchows Arch A Pathol Anat Histopathol 1992;421:513–519.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
McPherson, R.J., Wagner, C.L. (2001). The Effect of Pasteurization on Transforming Growth Factor Alpha and Transforming Growth Factor Beta 2 Concentrations in Human Milk. In: Newburg, D.S. (eds) Bioactive Components of Human Milk. Advances in Experimental Medicine and Biology, vol 501. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1371-1_70
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1371-1_70
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5521-2
Online ISBN: 978-1-4615-1371-1
eBook Packages: Springer Book Archive